U.S. Markets closed

Australian Clinical Labs Limited (ACL.XA)

CXA - CXA Real Time Price. Currency in AUD
3.0100-0.0600 (-1.95%)
At close: 03:59PM AEDT

Australian Clinical Labs Limited

1868-1892 Dandenong Road
Clayton, VIC 3168
61 3 9538 6777

Full Time Employees5,400

Key Executives

NameTitlePayExercisedYear Born
Ms. Melinda McGrathCEO & Exec. Director1.81MN/AN/A
Mr. James DavisonChief Financial Officer936.09kN/AN/A
Mr. Anthony FriedliChief Operating OfficerN/AN/AN/A
Mr. Sean JacksonChief Information OfficerN/AN/AN/A
Mr. Joe GeranNational Marketing DirectorN/AN/AN/A
Associate Prof. Tony LandgrenNational Medical Director & Chief PathologistN/AN/AN/A
Mr. Chris BrownlowChief Exec. Officer of New South Wales & Australian Capital TerritoryN/AN/AN/A
Ms. Shae SeymourChief Exec. Officer of Western AustraliaN/AN/AN/A
Mr. Eric SwaynChief Exec. Officer of South Australia & Northern TerritoryN/AN/AN/A
Ms. Eleanor Padman B.A., FCISCompany Sec.N/AN/AN/A
Amounts are as of December 31, 2022 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in AUD.


Australian Clinical Labs Limited provides pathology services in Australia. The company offers range of services, which include routine pathology test, advanced molecular genetics testing, harmony NIPT and first trimester screening, genetic carrier screening, chemical pathology, histopathology, and cytopathology; hematology, allergy, and immunology; serology and microbiology; and infectious molecular testing, cardiac testing services, functional pathology, veterinary pathology, and commercial drug and alcohol testing services. It offers its service to private and public hospitals. The company was incorporated in 2020 and is headquartered in Clayton, Australia.

Corporate Governance

Australian Clinical Labs Limited’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.